Cardiff Oncology (CRDF) Return on Equity [ROE] (2012 - 2026)
Cardiff Oncology (CRDF) posted Return on Equity [ROE] of -115.82% for Q2 2026, down 37.00 percentage points from -78.82% a year earlier.
Powered by 
Analysis
Cardiff Oncology (CRDF) Return on Equity [ROE] (2012 - 2026) Analysis & Trends
For FY2025, Cardiff Oncology's Return on Equity [ROE] came in at -71.46%, down 12.00 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -43.41 percentage points (FY2020 to FY2025).
- In prior years, Cardiff Oncology's Return on Equity [ROE] was -59.46% in FY2024 (-12.50 pp), -46.96% in FY2023 (-15.90 pp), -31.06% in FY2022 (-9.77 pp) and -21.29% in FY2021 (+6.76 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2020.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2021, with a gain of 39.34 percentage points; the weakest was Q2 2026, with a drop of 37.00 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,124.59 Bn | 1,093.18 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 634.91 Bn | 554.77 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.42 Bn | 478.53 Bn | 12.70 Bn | - |
| 4 | Merck | 357.53 Bn | 311.91 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 289.90 Bn | 253.89 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 264.89 Bn | 238.58 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.79 Bn | 193.19 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.74 Bn | 168.94 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.08 Bn | 117.73 Bn | 10.94 Bn | 4.97% |
| 10 | Cardiff Oncology | 61.59 Mn | 27.09 Mn | - | -115.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -115.82% |
| Dec 31, 2025 | -97.38% |
| Sep 30, 2025 | -93.91% |
| Jun 30, 2025 | -78.82% |
| Mar 31, 2025 | -63.48% |
| Dec 31, 2024 | -68.60% |
| Sep 30, 2024 | -84.36% |
| Jun 30, 2024 | -72.07% |
| Mar 31, 2024 | -61.60% |
| Dec 31, 2023 | -57.31% |
| Sep 30, 2023 | -51.52% |
| Jun 30, 2023 | -45.44% |
| Mar 31, 2023 | -40.31% |
| Dec 31, 2022 | -36.35% |
| Sep 30, 2022 | -34.26% |
| Jun 30, 2022 | -30.36% |
| Mar 31, 2022 | -25.50% |
| Dec 31, 2021 | -21.07% |
| Sep 30, 2021 | -18.96% |
| Jun 30, 2021 | -17.59% |
API Access
Cardiff Oncology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();